Assessing blood platelets as RNA biomarker source for prostate cancer.
Blood platelets may offer as RNA biomarker source for cancer as recently described for an oncogenic transcript in glioma patients and for PCA3 in prostate cancer (PCa) patients. Here, we elaborated on this aspect for PCa. PCA3 and other PCa-associated RNA markers were measured in platelets of PCa patients (cases) and healthy subjects (controls) in comparison to PCa cell lines by relative quantitative RT-PCR. The RNA markers displayed heterogeneous expression patterns in cell lines and platelets, however, without significant differences between cases and controls. The data do not support platelets as a profitable RNA source for early detection of PCa. Nonetheless, certain PCa-derived RNA markers in platelets may merit further investigation as potential prognostic biomarkers for PCa.